Financing type:  brokered private placement

Gross proceeds:  $13,798,850 (U.S.)

Offering:  21,229,000 common listed shares with 21,229,000 warrants

Offering price:  65 U.S. cents per listed share

Warrant exercise terms:  97 U.S. cents per listed share for a three-year period

Commissions in securities:  849,160 finders' warrants

Commission terms:  Each non-transferable warrant is exercisable at 97 U.S. cents for a 18-month period, subject to an acceleration right.

Disclosure:  Refer to the company's news releases dated Sept. 12, 2025, Sept. 29, 2025, Oct. 1, 2025, Oct. 3, 2025, and Nov. 3, 2025.